[Effect of L-dopa on some patterns of lipid metabolism in experimental animals].
L-DOPA, which is a metabolic precursor of catecholamines, reduced the manifestations of hyperlipidemia developed in animals after administration of Triton WR-1339, dexametasone or cholesterol. At the same time, L-DOPA decreased the rate of lipolysis, induced by adrenaline injection, as well as the content of 11-hydrocorticosteroids in blood plasma.
D000818:Animals; D002784:Cholesterol / Q000494:pharmacology; D003902:Detergents / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006949:Hyperlipidemias / Q000378:metabolism; D007980:Levodopa / Q000494:pharmacology*; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008297:Male; D051379:Mice; D011092:Polyethylene Glycols / Q000494:pharmacology; D051381:Rats
D003902:Detergents; D011092:Polyethylene Glycols; D007980:Levodopa; D003907:Dexamethasone; D002784:Cholesterol; C016811:tyloxapol; D004837:Epinephrine
Vliianie L-DOFA na nekotorye pokazateli lipidnogo obmena uéksperimental'nykh zhivotnykh.